{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:21:24Z","timestamp":1772767284275,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to investigate the association between saliva soluble angiotensin-converting enzyme 2 (sACE2) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adults<jats:bold>.<\/jats:bold> We selected a convenience sample of adults with post-acute SARS-CoV-2 infection and their household children living in quarantined family households of the metropolitan Barcelona region (Spain) during the spring 2020 pandemic national lockdown. Participants were tested for saliva sACE2 quantification by western blot and nasopharyngeal SARS-CoV-2 RT-PCR detection. A total of 161 saliva samples [82 (50.9%) from children; 79 (49.1%) from females] yielded valid western blot and RT-PCR results. Saliva sACE2 was detected in 79 (96.3%) children and 76 (96.2%) convalescent adults. Twenty (24.4%) children and 20 (25.3%) convalescent adults were positive for SARS-CoV-2 in nasopharynx by RT-PCR. SARS-CoV-2 RT-PCR-negative children had a significantly higher mean proportional level of saliva sACE2 (0.540 \u00d7 10<jats:sup>\u20133<\/jats:sup>%) than RT-PCR-positive children (0.192 \u00d7 10<jats:sup>\u20133<\/jats:sup>%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and convalescent adults (0.173 \u00d7 10<jats:sup>\u20133<\/jats:sup>%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). In conclusion, children negative for nasopharyngeal SARS-CoV-2 RT-PCR appear to exhibit a higher concentration of saliva sACE2 than SARS-CoV-2 RT-PCR-positive children and convalescent adults. Release of adequate levels of sACE2 in saliva could play a protective role against SARS-CoV-2. <\/jats:p>","DOI":"10.1038\/s41598-023-31911-2","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T14:03:29Z","timestamp":1681308209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between soluble angiotensin-converting enzyme 2 in saliva and SARS-CoV-2 infection: a cross-sectional study"],"prefix":"10.1038","volume":"13","author":[{"given":"Samuel","family":"Bru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Brotons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iolanda","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laia","family":"Alsina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desiree","family":"Henares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyes","family":"Carballar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariona Fernandez","family":"de Sevilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Barrabeig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Fumado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e0rbara","family":"Baro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan Marc","family":"Mart\u00ednez-L\u00e1inez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan J.","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quique","family":"Bassat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5222-8635","authenticated-orcid":false,"given":"Albert","family":"Balaguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Launes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Mu\u00f1oz-Almagro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"31911_CR1","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard. https:\/\/covid19.who.int\/. Accessed 22 Oct 2022 (2022)."},{"key":"31911_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.2162","volume":"212","author":"I Hamming","year":"2007","unstructured":"Hamming, I. et al. The emerging role of ACE2 in physiology and disease. J. Pathol. 212, 1\u201311 (2007).","journal-title":"J. Pathol."},{"key":"31911_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 395, 565\u2013574 (2020).","journal-title":"Lancet"},{"key":"31911_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming, I. et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631\u2013637 (2004).","journal-title":"J. Pathol."},{"key":"31911_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40249-020-00662-x","volume":"9","author":"MY Li","year":"2020","unstructured":"Li, M. Y., Li, L., Zhang, Y. & Wang, X. S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. Poverty 9, 45 (2020).","journal-title":"Infect. Dis. Poverty"},{"key":"31911_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280 (2020).","journal-title":"Cell"},{"key":"31911_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","volume":"12","author":"H Xu","year":"2020","unstructured":"Xu, H. et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 12, 8 (2020).","journal-title":"Int. J. Oral Sci."},{"key":"31911_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1042\/CS20200163","volume":"134","author":"D Batlle","year":"2020","unstructured":"Batlle, D., Wysocki, J. & Satchell, K. Soluble angiotensin-converting enzyme 2: A potential approach for coronavirus infection therapy?. Clin. Sci. (Lond.) 134, 543\u2013545 (2020).","journal-title":"Clin. Sci. (Lond.)"},{"key":"31911_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1113\/expphysiol.2007.040352","volume":"93","author":"RA Lew","year":"2008","unstructured":"Lew, R. A. et al. Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. Exp. Physiol. 93, 685\u2013693 (2008).","journal-title":"Exp. Physiol."},{"key":"31911_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10989-006-9031-6","volume":"12","author":"RA Lew","year":"2006","unstructured":"Lew, R. A. et al. Characterization of angiotensin converting enzyme-2 (ACE2) in human urine. Int. J. Pept. Res. Ther. 12, 283\u2013289 (2006).","journal-title":"Int. J. Pept. Res. Ther."},{"key":"31911_CR11","doi-asserted-by":"publisher","first-page":"F263","DOI":"10.1152\/ajprenal.00565.2017","volume":"315","author":"S Gutta","year":"2018","unstructured":"Gutta, S. et al. Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes. Am. J. Physiol. Renal Physiol. 315, F263\u2013F274 (2018).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"31911_CR12","doi-asserted-by":"publisher","first-page":"e970","DOI":"10.1093\/cid\/ciaa1721","volume":"72","author":"P Brotons","year":"2021","unstructured":"Brotons, P. et al. Susceptibility to severe acute respiratory syndrome coronavirus 2 infection among children and adults: A seroprevalence study of family households in the Barcelona metropolitan region, Spain. Clin. Infect. Dis. 72, e970\u2013e977 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"31911_CR13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/ofid\/ofaa210","volume":"7","author":"DL Hung","year":"2020","unstructured":"Hung, D. L. et al. Early-morning vs spot posterior oropharyngeal saliva for diagnosis of SARS-CoV-2 infection: Implication of timing of specimen collection for community-wide screening. Open Forum Infect. Dis. 7, 210 (2020).","journal-title":"Open Forum Infect. Dis."},{"key":"31911_CR14","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.3390\/v13081598","volume":"13","author":"P Brotons","year":"2021","unstructured":"Brotons, P. et al. The positive rhinovirus\/enterovirus detection and SARS-CoV-2 persistence beyond the acute infection phase: An intra-household surveillance study. Viruses 13, 1598 (2021).","journal-title":"Viruses"},{"key":"31911_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248\u2013254 (1976).","journal-title":"Anal. Biochem."},{"key":"31911_CR16","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan, R. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444\u20131448 (2020).","journal-title":"Science"},{"key":"31911_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41392-021-00809-8","volume":"6","author":"Y Gong","year":"2021","unstructured":"Gong, Y., Qin, S., Dai, L. & Tian, Z. The glycosylation in SARS-CoV-2 and its receptor ACE2. Signal Transduct. Target Ther. 6, 396 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"31911_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41588-020-00759-x","volume":"53","author":"C Blume","year":"2021","unstructured":"Blume, C. et al. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection. Nat. Genet. 53, 205\u2013214 (2021).","journal-title":"Nat. Genet."},{"key":"31911_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40709-019-0109-7","volume":"26","author":"KR Katsani","year":"2019","unstructured":"Katsani, K. R. & Sakellari, D. Saliva proteomics updates in biomedicine. J. Biol. Res. (Thessalon) 26, 17 (2019).","journal-title":"J. Biol. Res. (Thessalon)"},{"key":"31911_CR20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"V Monteil","year":"2020","unstructured":"Monteil, V., Kwon, H. & Prado, P. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181, 905\u2013913 (2020).","journal-title":"Cell"},{"key":"31911_CR21","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/S2213-2600(20)30418-5","volume":"8","author":"A Zoufaly","year":"2020","unstructured":"Zoufaly, A. et al. Human recombinant soluble ACE2 in severe COVID-19. Lancet Respir. Med. 8, 1154\u20131158 (2020).","journal-title":"Lancet Respir. Med."},{"key":"31911_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103316","volume":"66","author":"AM Nikiforuk","year":"2021","unstructured":"Nikiforuk, A. M. et al. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada. EBioMedicine 66, 103316 (2021).","journal-title":"EBioMedicine"},{"key":"31911_CR23","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1473-3099(20)30243-7","volume":"20","author":"R Verity","year":"2020","unstructured":"Verity, R. et al. Estimates of the severity of coronavirus disease 2019: A model-based analysis. Lancet Infect. Dis. 20, 669\u2013677 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"31911_CR24","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708\u20131720 (2020).","journal-title":"N. Engl. J. Med."},{"key":"31911_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jinf.2022.04.041","volume":"85","author":"D Jim\u00e9nez","year":"2022","unstructured":"Jim\u00e9nez, D. et al. Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2. J. Infect. 85, 86\u201389 (2022).","journal-title":"J. Infect."},{"key":"31911_CR26","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100051R","volume":"35","author":"MS Garc\u00eda-Ayll\u00f3n","year":"2021","unstructured":"Garc\u00eda-Ayll\u00f3n, M. S. et al. Plasma ACE2 species are differentially altered in COVID-19 patients. FASEB J. 35, e21745 (2021).","journal-title":"FASEB J."},{"key":"31911_CR27","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1164\/rccm.202004-1343LE","volume":"202","author":"EH Chang","year":"2020","unstructured":"Chang, E. H. et al. Rhinovirus infections in individuals with asthma increase ACE2 expression and cytokine pathways implicated in COVID-19. Am. J. Respir. Crit. Care Med. 202, 753\u2013755 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"31911_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"31911_CR29","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1165\/rcmb.2009-0203OC","volume":"43","author":"RS Zaheer","year":"2010","unstructured":"Zaheer, R. S. & Proud, D. Human rhinovirus-induced epithelial production of CXCL10 is dependent upon IFN regulatory factor-1. Am. J. Respir. Cell Mol. Biol. 43, 413\u2013421 (2010).","journal-title":"Am. J. Respir. Cell Mol. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31911-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31911-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31911-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T14:05:42Z","timestamp":1681308342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-31911-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["31911"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-31911-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"22 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5985"}}